chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccinated on Aug 13 and had a systemic body reaction starting Aug 20 and continuing through today. Seen by Internal Medicine on Aug 30. He was on medication at the time of vaccination - Zyrtec 10mg, Vistaril 25mg, Ranitidine 150mg.
she gave a patient the yellow fever vaccine and some leaked out with no reported adverse event; Initial information received  on 08-Jun-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves an unknown age and unknown gender patient who had she gave a patient the yellow fever vaccine and some leaked out with no reported adverse event after receiving vaccine yellow fever vaccine [yf-vax].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect yellow fever vaccine Solution for injection, lot number, strength, expiration date not reported via unknown route in unknown administration site for Prophylactic vaccination (immunisation).  On an unknown date the patient developed a non-serious she gave a patient the yellow fever vaccine and some leaked out with no reported adverse event (incorrect dose administered) (unknown latency)   Action taken was not applicable.  Outcome: Unknown for the event she gave a patient the yellow fever vaccine and some leaked out with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Immediate adverse reaction - Covid Arm. My arm became hot within hours, sore, inflamed and red and stayed that way for nearly one year. I still have a knot and at times an ache where the vaccine was given. After the shot I exhibited more low attention characteristics, more cloudy thinking and forgetfulness and sleeping more. After a couple of weeks I realized my vision had changed and I could not see as well. My boss and coworkers noticed my decreased vision change as well. I kept forgetting to make an eye appt. When I saw the eye doctor I was told I had 4th nerve palsey and and needed a CT. After CT I was sent to Neurologist for MRI where it was discovered I had had a stroke also.
Pt had no issues the first Pfizer dose, but after this dose, she started experiencing her typical anxiety symptoms. EMS was called 182/101 84 18 97%.  Pt c/o chest pressure 6/10, but she been having this discomfort for month, had an echo and saw a cardiologist 6 months ago.  BP remained, pt waited almost an hour total until she felt comfortable enough to drive 40 min home
Pt was hospitalized from 6/3-6/7 for severe hypercalcemia and diagnosed with diffuse metastatic renal cell cancer. He received his J and J vaccine on 5/14/21  and reported "everything went to downhill" with development of nausea, constipation, weight loss, weakness, poor appetite resulting in hospitalization with new severe hypercalcemia and acute functional decline and dx with metastatic renal cell cancer. pt was dx with a bladder tumor 3/19, underwent TURP with bladder biopsy and fulguration and cyctoscopy on 5/19/21. Prostate bx reveals benign nodular hyperplasia, bladder bx revealed urothelial dysplasia felt to be pre neoplastic. Urine Cytology from 4/14/21 negative for high grade urothelial cardinoma. with pamidronate treatment, lasix and ivf and calcitonin his hypercalcemia improved and he was discharged to follow up with oncology and urology as out pt.  He has since been readmitted on 6/22/21 with recurrent hypercalcemia and progressive decline.   biopsy with I.R. of left renal mass confirmed RCC, biopsy of LN was non-diagnostic.  per urology: Given the small size of the renal mass, it would be surprising if this was truly metastatic RCC,   this could be metastatic urothelial carcinoma given his history of high grade T1 disease, although the primary site and the urinary tract has presumably been eradicated of disease, metastatic disease prior to initial tumor eradication in the bladder remains a possibility.
Severe swelling the size of a baseball on R thigh with redness and warmth at and around injection site.
pt recvd vax;approx 2-3 hrs later,eyes rolled back,fainted & was non responsive;O2 given; unable to respond to command until pt arrived at er approx 1 hr later;
No additional AEs were reported; an expired PROQUAD was given to a patient; This spontaneous report was received from a registered nurse concerning an 18-month-old female patient. The patient's medical history and concurrent conditions were not provided. The patient's birth weight was 6Ib 11oz. She had one brother and two sisters. The patient was vaccinated with hepatitis b vaccine (reported as Hep B), diphtheria vaccine toxoid (+) pertussis vaccine acellular (+) polio vaccine inact (+) tetanus vaccine toxoid (reported as Polio, DTaP), haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (reported as Hib) and pneumococcal vaccine conj (PNEUMOCOCCAL CONJUGATE VACCINE) (reported as PCV) on 11-MAR-2022.  On 25-MAR-2022, the patient came into office for a nurse visit to catch up on immunization. On that day, she was vaccinated by the nurse, with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) 1 dose, (lot # T032144, expiration date: 20-MAR-2022, dose not reported) subcutaneously in the left vastus lateralis (also reported as left thigh) for prophylaxis (expired product administered). The nurse was trained and the vaccine was used according to the instruction leaflet. It was reported that the nurse realized the vaccine had expired 5 days prior upon charting. Pharmacy, supervisor, manufacturer and patient's mother were notified. The remaining doses of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) were disposed of. The patient had no reaction and no additional adverse event were reported (No adverse event).
underwent temperature excursion, They were to be used within 24 hours but administered to patients on unknown dates; Monovalent Vaccine 6 months to 5 years, underwent temperature excursion started on 21Feb2023; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (underwent temperature excursion, They were to be used within 24 hours but administered to patients on unknown dates), PRODUCT TEMPERATURE EXCURSION ISSUE (Monovalent Vaccine 6 months to 5 years, underwent temperature excursion started on 21Feb2023) and NO ADVERSE EVENT (No adverse event) in a child patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1903B) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (underwent temperature excursion, They were to be used within 24 hours but administered to patients on unknown dates), PRODUCT TEMPERATURE EXCURSION ISSUE (Monovalent Vaccine 6 months to 5 years, underwent temperature excursion started on 21Feb2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (underwent temperature excursion, They were to be used within 24 hours but administered to patients on unknown dates), PRODUCT TEMPERATURE EXCURSION ISSUE (Monovalent Vaccine 6 months to 5 years, underwent temperature excursion started on 21Feb2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (underwent temperature excursion, They were to be used within 24 hours but administered to patients on unknown dates) and PRODUCT TEMPERATURE EXCURSION ISSUE (Monovalent Vaccine 6 months to 5 years, underwent temperature excursion started on 21Feb2023).    No concomitant medication were reported.  It was reported that Monovalent Vaccine 6 months to 5 years, underwent temperature excursion started on 21-Feb-2023. They were to be used within 24 hours but administered to 24 patients on unknown dates. Vaccine administration dates and patient information were unknown.  Excursion Timeframe, on 21-Feb-2023, Max 8.60C for 10 hours and 57 minutes, on 22-Feb-2023 Max 8.5 C for 24 hours, on 23-Feb-2023 Max 8.5 C min 7.4 C for 17 hours and 56 minutes. No treatment information was provided by the reporter. This case was reported for patient 21 out of 24.   This case was linked to US-MODERNATX, INC.-MOD-2023-713467 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-713467:Patient 1 out of 24 Patients
Right now - red itchy, slighty swollen patch at vaccine site after approximately 14 days post shot- started itching the night before.
Pain at injection site. Starting the night of injection.  Pain lasted one week. Pain has persisted on and off ever since. (3 months) "Deep throbbing ache that goes all the way to the bone,from the injection site.  Occasionally seems to radiate down the arm. Keeps her awake at night."  Denies reddness, swelling of fever.
Feeling very tired, entire body is sore, neck is sore.  Temp keeps going up was 97.2 at 8 97.8 at 930 98.5 at 1130 was sent home from work.  Had covid november 16th feels like i have it all over again but without the breathing problems.
costochondritis the day after my 1st shot; still having pain from it; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COSTOCHONDRITIS (costochondritis the day after my 1st shot) and PAIN (still having pain from it) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COSTOCHONDRITIS (costochondritis the day after my 1st shot) and PAIN (still having pain from it). At the time of the report, COSTOCHONDRITIS (costochondritis the day after my 1st shot) and PAIN (still having pain from it) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided No Treatment information provided    Reporter did not allow further contact
pt's mom called the clinic & states pt was having a rxn to shot-eyes were swollen;mom told to call EMS-mom called back stated EMS stated pt's BP was okay
Headache; Body aches; Fever; Chills; Nausea; enlarged lymph nodes found in a mammogram.; This is a spontaneous report from a contactable Consumer (patient, reported for self). A 44-years-old (non-pregnant) female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EL3247) via an unspecified route of administration in arm left on 17Mar2021 10:15 (age at vaccination 44 years) as dose 2, single for COVID-19 immunization. Patient was not pregnant at the time of vaccination. The patient medical history was not reported. Patient received no other vaccine in four weeks, had no COVID prior vaccination. Patient had no known allergies. Other medical history were none. Patient received concomitant therapy/ Other medications in two weeks (unspecified). Patient had earlier received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EL3247) via an unspecified route of administration in right arm on 24Feb2021 10:15 (age at vaccination 44 years) as single dose for COVID-19 immunization. On 17Mar2021 23:00, the patient experienced headache, body aches, fever, chills, nausea and enlarged lymph nodes found in a mammogram. Patient had not tested COVID post vaccination. The patient underwent lab test and procedures which includes enlarged lymph nodes found in a mammogram (17Mar2021). Patient had not received treatment for the adverse events. The outcome of the events was recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
fever 101, arm so sore could not lift it,  headache, chills, severe fatigue, body aches, nausea that lasted for just over 48 hours
BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON 08/04/2021. PATIENT FULLY VACCINATED ON 02/13/2021.
Migraine headache 3 days, tired, rash at sight eye sensitivity Have never had a migraine before.  All 7 days after vaccine
This report of wheezing is being submitted in an expedited time frame as requested by the FDA. Information regarding Flumist live intranasal solution was received from a nurse regarding her 12 year old daughter who developed wheezing. At 12 years of age, the patient received a dose on 12/19/03. The patient had no relevant medical history. She had no history of asthma or wheezing. Indication for Flumist was immunization. Product was administered on 12/19/03. Dose regimen was 1 dose (IN). Patient was not taking concomitant therapy. On 12/19/03, the evening of vaccination, the patient began wheezing. She was treated with Ventolin nebulizations and an unspecified steroid inhaler. As of 1/16/03, her symptoms persisted and treatment continued. No additional information was available at the date of this report. (OMIC)
NAUSEA, HEADACHE, BODY ACHE Nausea started 30 min after injection then subsided the next day. Headache and body aches occurred next day.
The leg that was injected with the DTAP shot swelled to double its size and stayed that way for an entire 6 weeks.
About an hour after the shot I felt nauseous and light-headed and a little mild weakness. It sort of came in mild waves over the course of 2 to 3 hours. Never really disabled me just bothersome and made me want to just sit. Symptoms seemed to disappear after I ate supper.  I felt fine the next morning save fore some soreness just below the injection site.
The patient is a 90 y.o. female with a history of PE/DVT 6/2022 completed 3 months of Xarelto, Hypertension, Hyperlipidemia, GERD, Ulcerative colitis, Anemia, Arthritis, admitted with COVID-19 and generalized weakness. When she progressed, she was discharged HHC in stable but guarded condition with advice for all time fall precautions and OP f/u with her physicians as instructed.   Acute respiratory failure with hypoxia-resolved Covid-19 Virus Infection Date of onset of symptoms: 10/17/2022 Symptoms present on admission: Cough, dyspnea, rhinorrhea, loss of taste/smell, nausea, fever/chills Date of covid positive test: 10/18/2022 Vaccination status: vaccinated, f/u with PCP for need for booster in near future Imaging: CTPA negative for PE, revealed bilateral bronchial wall thickening and scattered bilateral lung opacities Oxygen requirements on admission: 2 L Current oxygen requirements: RA Medical therapy: remdesivir and steroids(Day #4), resume home prednisone taper on discharge Consultants following: None Anticipated special isolation end date: 10/29/2022 Weaned to RA and did not need home o2 on discharge Cough better OP PCP f/u as instructed     SIRS criteria- improved WBC 12.31, tachycardia Likely secondary to COVID-19 Blood cultures-NGTD.  LA normal     New onset atrial fibrillation with RVR, prozsymal Converted to NSR following 10 mg IV Cardizem in ED proBNP 613.  TSH normal.  Serial troponins with a flat trend 21> 21 Echo from June 2022 with EF greater than 70% RVSP 42 mmHg, moderate TR Cardiology followed in the hospital Continue home Rx Toprol-XL 25 mg daily Cardiology started AC with Xarelto 15 mg daily OP Cardio f/u as instructed   Chronic normocytic anemia Baseline hemoglobin 9.7 to 11 g/dL H&H 9.9/31.7 OP PCP f/u    Generalized weakness Up with assistance PT/OT evaluated-recommended home therapy and qualified for HHC on discharge C/w wheeled walker and all time fall precautions  Essential hypertension ontinue Toprol and hydrochlorothiazide   Ulcerative colitis Started on prednisone taper 10/1-will held while receiving Decadron>resume on discharge Continue Entocort Pepcid for a month ordered OP PCP f/u recommended   History of recent PE Saddle PE with extensive bilateral emboli with heart strain in June 2022 Completed 3 months of Xarelto Admission CTPA with no evidence of PE
Approximately 5 minutes after receiving the booster dose of Moderna the client became lethargic and experienced chest pains. O2 SATs were at 75-80. 2 liters of O2 was started. O2 SATs went up to 98 and then dropped again. 4 liters of O2 was then started and 911 was called. Client was transported to the emergency room.
I've had a headache 24/7 for almost 9 months. It started after the booster and presented as a mild headache with some lightheadedness; I've had a headache 24/7 for almost 9 months. It started after the booster and presented as a mild headache with some lightheadedness; I had hyper-sensitivity to sound and motion during months 3 and 4.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64-year-old male patient received BNT162b2 (BNT162B2), on 13Sep2021 at 12:30 as dose 3 (booster), single (Lot number: FC3182) at the age of 63 years, in left arm for covid-19 immunization. The patient's relevant medical history included: "Intolerance for onions and garlic" (unspecified if ongoing). Concomitant medication(s) included: FAMOTIDINE. Vaccination history included: BNT162b2 (Dose Number: 2, Batch/Lot No: EP75134, Vaccine Administration Time: 02:30 PM), administration date: 17Mar2021, when the patient was 63-year-old, for Covid-19 Immunization; BNT162b2 (Dose Number: 1, Batch/Lot No: EN6203, Location of injection: Arm Left, Vaccine Administration Time: 11:30 AM), administration date: 24Feb2021, when the patient was 63-year-old, for Covid-19 immunization. The following information was reported: HYPERACUSIS (disability) with onset 14Sep2021, outcome "not recovered", described as "I had hyper-sensitivity to sound and motion during months 3 and 4."; HEADACHE (disability), DIZZINESS (disability) all with onset 14Sep2021, outcome "not recovered" and all described as "I've had a headache 24/7 for almost 9 months. It started after the booster and presented as a mild headache with some lightheadedness". The events "i've had a headache 24/7 for almost 9 months. it started after the booster and presented as a mild headache with some lightheadedness" and "i had hyper-sensitivity to sound and motion during months 3 and 4." required physician office visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: Nasal Swab Covid test name post vaccination: PCR, Cue, etc. Therapeutic measures were taken as a result of headache, dizziness, hyperacusis and included treatment with amitriptyline, rizatriptan, Topamax and prednisone. Clinical course: The patient did not receive any other vaccines within four weeks prior to the vaccination. Other medications in two weeks: Famotidine. Prior to the vaccination, the patient was not diagnosed with COVID-19. I have had a headache 24/7 for almost 9 months. It started after the booster and presented as a mild headache with some lightheadedness. After 3 months it felt more like a regular headache, still 24/7. I had hypersensitivity to sound and motion during months 3 and 4. Since the vaccination, the patient had been tested for COVID-19 (Covid test type post vaccination: Nasal swab, Covid test name post vaccination: PCR, Cue, etc).  No follow-up attempts are possible. No further information is expected.
pt called office & 8AM on 18AUg93 c/o poss lt deltoid tetanus inject react on 17AUg93; hard lump, red, warm & inc temp, body aches, sweats;
This case was reported by a consumer via call center representative and described the occurrence of atrial fibrillation in a 73-year-old female patient who received SHINGRIX for prophylaxis. On 7th January 2019, the patient received the 1st dose of SHINGRIX (intramuscular). On 7th January 2019, less than a day after receiving SHINGRIX, the patient experienced injection site pain. On 8th January 2019, the patient experienced atrial fibrillation (serious criteria hospitalization and GSK medically significant). On an unknown date, the outcome of the atrial fibrillation and injection site pain were unknown. It was unknown if the reporter considered the atrial fibrillation and injection site pain to be related to SHINGRIX. Additional details were provided as follows: The patient experienced soreness at injection site and that next day she felt her heartbeat and went to emergency room and was admitted to hospital overnight and diagnosed with atrial fibrillation. The patient was discharged the next day. The patient consented to follow up.
Within 3 hours of getting the johnson and johnson shot, I was in bed with a high fever (101.0).  I had chills, a massive headache, sensitivity to light, aching all over, no energy, and just wanted to sleep.  This went on for 3 days of up and down temperatures and chills.  Could not get out of bed and don't remember much of the 3 days.  Tried to drink lots of water and took Acetaminophen every 3 hours if I was awake.  I have never felt so bad in my life because I am a person who rarely gets sick.
Pain and weakness in upper left arm following vaccination on 10/13/15. KENALOG 40 mg injection 11/3/15. Pain still ongoing but improving.
Hours after the vaccine was administered, patient began to experience a rash and then petechiae and severe itching, then hives.
Information has been received from a 56 year old female consumer who is also a Registered Nurse, with no pertinent medical history and no known drug allergies who reported that on 21-APR-2010, some of a dose of VARIVAX (Merck) splashed in her right eye during administration of vaccine to a patient. There was no concomitant medication. The registered nurse stated that she rinsed her eye twice and her eye was slightly itchy before second rinse but at the time of the report it was fine. The patient did not seek medical attention. This is one of several reports from the same source. No further information is available.
MODERNA COVID VACCIE WAS GIVEN OFF LABEL.  THE MANUFACTUER WERE CONTACTED AND THE PATIENT REPORTS NO ADVERSE REACTIONS.
Approximately around 2 months after my booster shot I tested positive for COVID 19 and experienced the following symptoms: Sore throat (Swollen tonsils), Fever, Headache, Cough, Knee pain. My sore throat lasted for about 1-2 days (I took antibiotic for treatment), and for the other symptoms stated above lasted for about 5 days except for the headache which I am still experiencing as of the moment.
Left deltoid region with 5cm x 4cm erythematous, warm, indurated, tender area. No fever. Treated with KEFLEX and topical steroid.
2nd Hep B vaccine administered 7/31/23. 8/1/23 experienced onset of side effects: double / blurred vision, nausea, severe headache. Nausea was alleviated with anti-nausea med and headache with Tylenol and sleep. 8-3 woke up with slight fever nausea and headache remaining.